Skip to main content
Journal cover image

Pulsed delivery of inhaled nitric oxide to patients with primary pulmonary hypertension: An ambulatory delivery system and initial clinical tests

Publication ,  Journal Article
Channick, RN; Newhart, JW; Johnson, FW; Williams, PJ; Auger, WR; Fedullo, PF; Moser, KM
Published in: Chest
January 1, 1996

Background: Inhaled nitric oxide (NO) has been shown to be a selective pulmonary vasodilator in certain patients with primary pulmonary hypertension (PPH). Objectives: The purpose of this study was to design and test a system for delivery of NO to awaken, ambulatory patients with PPH and to evaluate this system in the home setting. Methods: The ambulatory delivery system consisted of a tank of 80 ppm of NO (balance N2), a modified gas-pulsing device, and nasal cannulas. The pulsing device was set to deliver NO for 0.1 s at the beginning of each inspiration. Results: Using this system eight patients with PPH were studied with pulmonary artery catheters in place. Inhalation of NO led to significant reductions in both mean pulmonary arterial pressure (PAPm) (51±12 to 43±10 mm Hg; p=0.001) and pulmonary vascular resistance (PVR) (790±285 to 620±208 dyne · s · cm-5; p=0.01). Three of the eight patients had both greater than 20% and greater than 30% decreases in PAPm and PVR, respectively. No exhaled NO or NO2 was detectable in any of the eight patients. One patient was discharged home from the hospital on a regimen of inhaled NO. At 9 months, no adverse effects were noted and the system was working well. Conclusions: Pulsed delivery of inhaled NO to ambulatory patients with PPH, via nasal prongs, is feasible and, in some patients, leads to significant improvement in pulmonary hypertension. Inhaled 09NO, therefore, may have a role in the long-term treatment of patients with PPH.

Duke Scholars

Altmetric Attention Stats
Dimensions Citation Stats

Published In

Chest

DOI

ISSN

0012-3692

Publication Date

January 1, 1996

Volume

109

Issue

6

Start / End Page

1545 / 1549

Related Subject Headings

  • Respiratory System
  • 3202 Clinical sciences
  • 3201 Cardiovascular medicine and haematology
  • 1103 Clinical Sciences
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Channick, R. N., Newhart, J. W., Johnson, F. W., Williams, P. J., Auger, W. R., Fedullo, P. F., & Moser, K. M. (1996). Pulsed delivery of inhaled nitric oxide to patients with primary pulmonary hypertension: An ambulatory delivery system and initial clinical tests. Chest, 109(6), 1545–1549. https://doi.org/10.1378/chest.109.6.1545
Channick, R. N., J. W. Newhart, F. W. Johnson, P. J. Williams, W. R. Auger, P. F. Fedullo, and K. M. Moser. “Pulsed delivery of inhaled nitric oxide to patients with primary pulmonary hypertension: An ambulatory delivery system and initial clinical tests.” Chest 109, no. 6 (January 1, 1996): 1545–49. https://doi.org/10.1378/chest.109.6.1545.
Channick RN, Newhart JW, Johnson FW, Williams PJ, Auger WR, Fedullo PF, et al. Pulsed delivery of inhaled nitric oxide to patients with primary pulmonary hypertension: An ambulatory delivery system and initial clinical tests. Chest. 1996 Jan 1;109(6):1545–9.
Channick, R. N., et al. “Pulsed delivery of inhaled nitric oxide to patients with primary pulmonary hypertension: An ambulatory delivery system and initial clinical tests.” Chest, vol. 109, no. 6, Jan. 1996, pp. 1545–49. Scopus, doi:10.1378/chest.109.6.1545.
Channick RN, Newhart JW, Johnson FW, Williams PJ, Auger WR, Fedullo PF, Moser KM. Pulsed delivery of inhaled nitric oxide to patients with primary pulmonary hypertension: An ambulatory delivery system and initial clinical tests. Chest. 1996 Jan 1;109(6):1545–1549.
Journal cover image

Published In

Chest

DOI

ISSN

0012-3692

Publication Date

January 1, 1996

Volume

109

Issue

6

Start / End Page

1545 / 1549

Related Subject Headings

  • Respiratory System
  • 3202 Clinical sciences
  • 3201 Cardiovascular medicine and haematology
  • 1103 Clinical Sciences